Evercore ISI lowered the firm’s price target on Iqvia (IQV) to $240 from $260 and keeps an Outperform rating on the shares ahead of Q3 earnings from the healthcare tech and distribution group. In the group, the firm’s top picks include CVS Health (CVS), its top large cap pick, Iqvia and R1 RCM (RCM), the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IQV:
- Iqvia price target lowered to $229 from $250 at Mizuho
- Iqvia enters pact with Argenx to provide safety systems, services
- Iqvia price target lowered to $245 from $250 at Barclays
- Iqvia initiated with a Buy at HSBC
Questions or Comments about the article? Write to editor@tipranks.com